Risk Factors and Outcomes in Patients With Stable Coronary Artery Disease and Coronary Chronic Total Occlusion.

This article provides information about a clinical trial conducted at Ruijin Hospital in China. The trial aims to study coronary artery disease and the development of coronary collateral circulation. The study will involve patients with good and poor coronary collaterals, and the development of collateral circulation will be graded according to the Rentrop score. The trial is currently recruiting participants, with an estimated enrollment of 3000 and an estimated completion date of March 1, 2027. The eligibility criteria include age 18 years and older, patients with angina or silent ischemia and documented ischemia, and patients with chronic total occlusion (CTO) for at least 3 months. The trial does not accept patients with certain conditions such as chronic heart failure with NYHA grade ≥3, a history of coronary artery bypass grafting, or recent percutaneous coronary intervention. The trial is open to all sexes and is being conducted in China. The primary contact for the trial is Fenghua Ding, PhD, MD, and the NCT number is NCT06137521. The responsible party for the trial is Ruijin Hospital. [Extracted from the article]

Copyright of Heart Disease Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)